Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tina R. Juhl"'
Autor:
Verusca Lecchi, Pamela Surtees, Jessie A. Hermann, Marina Noutsou, Lidmila Francová, Francesca Lo Bue, Silvia Prandini, Annika Durban, Heidrun Wölk, Suzy van Steenderen, Gemma Currie, Rüdiger Göke, Ivan Rychlik, Daniela Cugini, Annette Busmann, Ulrike Wittkop, Svitlana Yakymchuk, John R. Petrie, Slavica S. Stratrova, Stanley M H Yeung, Julia Raad, Antonio Cannata, Ninna Hahn Tougaard, Robbie Wilson, Barbara Neuhaus, Joachim Beige, Olivera Stojceva-Taneva, Harald Mischak, Tine W. Hansen, Giulia Gherardi, Caroline Boukens-de Graaf, Renata Amanaki, Francesco Nones, Anneke K. De Bruin, Aneliya Parvanova, Elizabeth Douglas, Carolina Aparicio, Gerjan Navis, Tereza Havrdova, Alberto Ortiz, Maria Dolores Sanchez-Niño, Simone Theilade, Ferrina Clerc-de Jong, Signe Abitz Winther, Adrian M. Ramos, Regina Ax-Smolarski, Ingo Dimos, Christina M. Gant, Peter Girman, Friedrich W. Petry, Peter Rossing, Bruno Lapauw, Katarina Adamova, Rikke J. Stefansen, Michael Prigge, Mie K. Eickhoff, Petra Zürbig, Viktor Rotbain Curovic, Davide Villa, Goce Spasovski, Marian Nannings, Adriaan Kooy, Joanne Flynn, Therese Frost Lerche, Veit Zieglschmid, Flavio Gaspari, Gjulsen Selim, Marijn M. Speeckaert, Jens C. Laursen, Elsie de Man, Signe Rosenlund, Christian Delles, Giel Nijpels, Katriona Brooksbank, Alessandro Villa, Ilian Iliev, Morten Lindhardt, Maria A. Campbell, Lone Jelstrup, Gozewijn D. Laverman, Matias Trillini, Ulrike Schmidt, Kristin Kreutzmann, Silke Zimmermann, Ceyda Kilic, Tina R. Juhl, Silvia Ferrari, Nadia Stucchi, Beatriz Fernandez-Fernandez, Christian Stevns Hansen, Femke Rutters, Brenda Wierbos, Sabien Inion, Maria Lajer, Justyna Siwy, Jannet Entius, Sascha Pilemann-Lyberg, Lene Aabo, Heiko von der Leyen, Elina Eldeik, Tatjana Gjorgovski, Marie Frimodt-Møller, Isabelle Dewettinck, Maja L.D. Halkjær, Joline W.J. Beulens, Šárka Albrechtová, Stephan J. L. Bakker, Hiddo J.L. Heerspink, Brit Rädisch, Clotilde Vázquez, Ilse J. M. Hagedoorn, Dorthe Riis, Bernt Johan von Scholten, Andreas L. Birkenfeld, Kelly Rokegem, Ana Belen Sanz, Frederik Persson, Eva Bollweber, Anika Hävemeier, Frank Huvers, Petra Schutten-Westerneng, Piero Ruggenenti, Sharon Kean, Maria Á. Gonzalo, Anne G. Lundgaard, Marco Schiemann, Emilie H. Zobel, Nete Tofte, Joe Galloway, Daniela Melacini, Jinny Sanchez-Rodriguez
Publikováno v:
Lancet Diabetes & Endocrinology, 8(4), 301-312. ELSEVIER SCIENCE INC
Tofte, N, Lindhardt, M, Adamova, K, Bakker, S J L, Beige, J, Beulens, J W J, Birkenfeld, A L, Currie, G, Dimos, I, Francová, L, Frimodt-Møller, M, Girman, P, Göke, R, Havrdova, T, Heerspink, H J L, Kooy, A, Laverman, G D, Mischak, H, Navis, G, Nijpels, G, Noutsou, M, Ortiz, A, Parvanova, A, Persson, F, Petrie, J R, Ruggenenti, P L, Rutters, F, Rychlík, I, Siwy, J, Spasovski, G, Speeckaert, M, Trillini, M, Zürbig, P, von der Leyen, H, Rossing, P, PRIORITY investigators & Nijpels, MGAAM 2020, ' Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY) : a prospective observational study and embedded randomised placebo-controlled trial ', The Lancet Diabetes and Endocrinology, vol. 8, no. 4, pp. 301-312 . https://doi.org/10.1016/S2213-8587(20)30026-7
Ann Transl Med
The Lancet Diabetes and Endocrinology, 8(4), 301-312. Elsevier BV
Lancet Diabet. Endocrinol. 8, 301-312 (2020)
Tofte, N, Lindhardt, M, Adamova, K, Bakker, S J L, Beige, J, Beulens, J W J, Birkenfeld, A L, Currie, G, Dimos, I, Francová, L, Frimodt-Møller, M, Girman, P, Göke, R, Havrdova, T, Heerspink, H J L, Kooy, A, Laverman, G D, Mischak, H, Navis, G, Nijpels, G, Noutsou, M, Ortiz, A, Parvanova, A, Persson, F, Petrie, J R, Ruggenenti, P L, Rutters, F, Rychlík, I, Siwy, J, Spasovski, G, Speeckaert, M, Trillini, M, Zürbig, P, von der Leyen, H, Rossing, P, PRIORITY investigators & Nijpels, MGAAM 2020, ' Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY) : a prospective observational study and embedded randomised placebo-controlled trial ', The Lancet Diabetes and Endocrinology, vol. 8, no. 4, pp. 301-312 . https://doi.org/10.1016/S2213-8587(20)30026-7
Ann Transl Med
The Lancet Diabetes and Endocrinology, 8(4), 301-312. Elsevier BV
Lancet Diabet. Endocrinol. 8, 301-312 (2020)
Background: \ud Microalbuminuria is an early sign of kidney disease in people with diabetes and indicates increased risk of cardiovascular disease. We tested whether a urinary proteomic risk classifier (CKD273) score was associated with development o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c330f7cf6c46dc4a204c768eaea4bed
https://eprints.gla.ac.uk/212534/13/212534.pdf
https://eprints.gla.ac.uk/212534/13/212534.pdf
Autor:
Hans-Henrik Parving, Henrik Reinhard, Frans Boomsma, Coen D.A. Stehouwer, Erik Frandsen, Frederik Persson, Casper G. Schalkwijk, Peter Rossing, Tina R. Juhl, A.H. Jan Danser
Publikováno v:
Diabetes Care
Diabetes Care, 32(10), 1873-1879. American Diabetes Association Inc.
Diabetes Care, 32(10), 1873-1879. American Diabetes Association
Diabetes Care, 32(10), 1873-1879. American Diabetes Association Inc.
Diabetes Care, 32(10), 1873-1879. American Diabetes Association
OBJECTIVE We investigated whether the antiproteinuric effect of the direct renin inhibitor aliskiren is comparable to that of irbesartan and the effect of the combination. RESEARCH DESIGN AND METHODS This was a double-blind, randomized, crossover tri
Autor:
K. J. Schjoedt, Erik Frandsen, Frederik Persson, H.-H. Parving, Frans Boomsma, Casper G. Schalkwijk, Tina R. Juhl, Peter Rossing, Lise Tarnow, Coen D.A. Stehouwer
Publikováno v:
Kidney International, 73, 1419-25. Elsevier Science
Kidney International, 73(12), 1419-1425. Elsevier Inc.
Kidney International, 73(12), 1419-1425. Elsevier Inc.
Inhibition of renin with an active site inhibitor, aliskiren, lowers blood pressure (BP) in diabetic patients. Here, we studied the time course of the antihypertensive and antiproteinuric effect of renin inhibition in 15 patients with type 2 diabetes
Autor:
Lise Tarnow, Hans-Henrik Parving, Kasper Rossing, Tina R. Juhl, K. J. Schjoedt, Peter Rossing, Frans Boomsma
Publikováno v:
Kidney International, 70(3), 536-542. Elsevier Inc.
Reduction of nephrotic range albuminuria is associated with markedly improved renal and cardiovascular outcome in patients with diabetic nephropathy. Aldosterone has been suggested to play a role in the progression of diabetic nephropathy. We therefo
Autor:
Hans-Henrik Parving, Peter Karl Jacobsen, Steen Andersen, Peter Rossing, Lise Tarnow, Tina R. Juhl
Publikováno v:
Capital Region of Denmark
BACKGROUND Blockade of the renin-angiotensin system is the primary target in the treatment of diabetic kidney disease. Angiotensin II subtype 1 (AT1) receptor antagonists reduce albuminuria and lower blood pressure, but the initial time course of the
Autor:
Tina R. Juhl, Henrik Reinhard, Peter Rossing, Casper G. Schalkwijk, Frans Boomsma, A. H. J. Danser, Coen D.A. Stehouwer, H.-H. Parving, Frederik Persson, Erik Frandsen
Publikováno v:
Diabetologia, 53(8), 1576-1580. Springer-Verlag
Diabetologia, 53(8), 1576-1580. Springer, Cham
Diabetologia, 53(8), 1576-1580. Springer, Cham
AIM: The optimal antiproteinuric dose of aliskiren is unknown. This study compared the effect of placebo and increasing doses of aliskiren on urinary albumin excretion rate (UAER). METHODS: The trial was a double-blind crossover design. Twenty-six pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6ecacc2e2af104beffc0dc3b2478f6e
https://pure.eur.nl/en/publications/30f24fda-76d4-4b39-9ea1-65e9ce51d03e
https://pure.eur.nl/en/publications/30f24fda-76d4-4b39-9ea1-65e9ce51d03e
Autor:
Lise Tarnow, Tina R. Juhl, Hans-Henrik Parving, Peter Rossing, Jaap Deinum, Steen Andersen, Francois Cambien
Publikováno v:
Kidney International, 62, 192-198. Elsevier Inc.
Kidney International. Supplement, 62, 1, pp. 192-8
Kidney International. Supplement, 62, 192-8
Kidney International. Supplement, 62, 1, pp. 192-8
Kidney International. Supplement, 62, 192-8
Renoprotective effects of losartan in diabetic nephropathy: Interaction with ACE insertion/deletion genotype?BackgroundThe beneficial short- and long-term renoprotective effects of angiotensin I-converting enzyme (ACE) inhibition are lower in albumin
Publikováno v:
Nephrology, Dialysis, Transplantation, 17, 8, pp. 1413-8
Capital Region of Denmark
Nephrology Dialysis Transplantation, 17, 1413-1418. Oxford University Press
Nephrology, Dialysis, Transplantation, 17, 1413-8
Capital Region of Denmark
Nephrology Dialysis Transplantation, 17, 1413-1418. Oxford University Press
Nephrology, Dialysis, Transplantation, 17, 1413-8
Item does not contain fulltext BACKGROUND: Angiotensin II subtype-1 receptor antagonists represent a valuable new class of drugs in the treatment of diabetic nephropathy. The aim of our study was to evaluate the optimal dose of losartan for renoprote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e1dff1bf78d25efc0304744009694aa
https://hdl.handle.net/2066/185432
https://hdl.handle.net/2066/185432
Autor:
Kasper Rossing, Lise Tarnow, Hans-Henrik Parving, Peter Rossing, Tina R. Juhl, K. J. Schjoedt, Frans Boomsma
Publikováno v:
Kidney International, 68(6), 2829-2836. Elsevier Inc.
Beneficial impact of spironolactone in diabetic nephropathy.BackgroundAldosterone has been suggested to play a role in the initiation and progression of diabetic nephropathy. Currently recommended treatment with angiotensin-converting enzyme (ACE) in
Autor:
Hans-Henrik Parving, Tina R. Juhl, François Cambien, Lise Tarnow, Steen Andersen, Peter Rossing, Jaap Deinum
Publikováno v:
Capital Region of Denmark
Andersen, S, Tarnow, L, Cambien, F, Rossing, P, Juhl, T R, Deinum, J & Parving, H-H 2003, ' Long-term renoprotective effects of losartan in diabetic nephropathy ', Diabetes Care, vol. 26, pp. 1501-1506 .
Diabetes Care, 26(5), 1501-1506. American Diabetes Association Inc.
Andersen, S, Tarnow, L, Cambien, F, Rossing, P, Juhl, T R, Deinum, J & Parving, H-H 2003, ' Long-term renoprotective effects of losartan in diabetic nephropathy ', Diabetes Care, vol. 26, pp. 1501-1506 .
Diabetes Care, 26(5), 1501-1506. American Diabetes Association Inc.
OBJECTIVE—Several observational follow-up studies have found that the D allele of the insertion (I)/deletion (D) polymorphism of the ACE gene (ACE/ID) is associated with an increased risk of renal function loss, even during ACE inhibition. Therefor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af7fb882fa6f74e9b722bcedcce37cef
https://research.regionh.dk/en/publications/longterm-renoprotective-effects-of-losartan-in-diabetic-nephropathy(194d2ea0-1075-47eb-a4da-6b4e475f7c4d).html
https://research.regionh.dk/en/publications/longterm-renoprotective-effects-of-losartan-in-diabetic-nephropathy(194d2ea0-1075-47eb-a4da-6b4e475f7c4d).html